Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Commonalities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Search alternatives
:
commonalities »
communities
,
commodities
Showing
1
-
20
of
729
Search:
'"Commonalities"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Sofosbuvir (Sovaldi) : sofosbuvir is indicated for the treatment of chronic hepatitis C virus (CHC) infection in adult patients with compensated liver disease, including cirrhosis
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
2
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
3
CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
4
CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
5
CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
6
CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
7
CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
8
CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
9
Fluticasone furoate/Vilanterol (Breo ellipta)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
10
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
11
Sofosbuvir (Sovaldi) : sofosbuvir is indicated for the treatment of chronic hepatitis C virus (CHC) infection in adult patients with compensated liver disease, including cirrhosis
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
12
CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
13
Asfotase alfa (Strensiq)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
14
CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
15
Entyvio (Vedolizumab)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
16
Ustekinumab (Stelara) injection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
17
Ivacaftor (Kalydeco) 150 mg tablet : for treatment of cystic fibrosis with G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R, or G970R mutation
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
18
Eplerenone (Inspra) (25 mg tablet and 50 mg tablet) : as an adjunct to standard therapy to reduce the risk of cardiovascular mortality and hospitalization for heart failure in pati...
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
19
Macitentan (Opsumit) : for long-Term treatment of pulmonary arterial hypertension
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
20
Propranolol hydrochloride (Hemangiol)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
530
330 - Economics
213
700 - The arts; fine & decorative arts
71
140 - Specific philosophical schools
70
580 - Plants (Botany)
11
380 - Commerce, communications & transportation
7
more ...
615 - Pharmacology & therapeutics
4
see all ...
less ...
Language
English
729
Collection
National Center for Biotechnology Information
729
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
161
Canadian Diabetes Association
4
Kidney Foundation of Canada
2
Multiple Sclerosis Society of Canada
2
Recently Uploaded
Last Month
64
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22Commonalities%22&type=Series
Send by Email
×
Loading...